{"entity":{"id":"nct07466160","kind":"trial","name":"A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of Cisplatin and Carboplatin in advanced solid tumours, run by Mabwell (Shanghai) Bioscience Co., Ltd., now recruiting.","summary":"A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07466160 by Mabwell (Shanghai) Bioscience Co., Ltd., with 280 participants planned, started 2026-02-11 and due to reach its primary completion in 2027-12-31. Interventions recorded: 7MW3711, JS207, Cisplatin and Carboplatin.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07466160","url":"https://clinicaltrials.gov/study/NCT07466160"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["cisplatin","carboplatin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07466160","phase":"1/2","setting":"A Multi-center, Open-label, Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Preliminary Efficacy of 7MW3711 in Combination With JS207 With or Without Chemotheray in Patients With Advanced Solid Tumors","sponsor":"Mabwell (Shanghai) Bioscience Co., Ltd.","enrolled":280,"outcomes":[]},"route":"/trials/nct07466160/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"cisplatin","kind":"drug","name":"Cisplatin","route":"/drugs/cisplatin/"}]}}